Theron Pharmaceuticals, Inc. Email Format
Pharmaceutical ManufacturingCalifornia, United States0-1 Employees
Theron Pharmaceuticals, Inc. is a small privately held biotechnology company based in Sunnyvale, California, operating within the pharmaceutical manufacturing sector. It is developing a long-acting antagonist of the M3 muscarinic receptor aimed at improving treatment for chronic respiratory diseases, including COPD and severe asthma. The program seeks to produce a once-daily inhaled bronchodilator that supports use across multiple inhalation devices. In addition, the product is designed to be compatible with co-formulations for potential multi-drug therapies. By focusing on delivery-device flexibility and co-formulation potential, Theron addresses the needs of patients who require long-term bronchodilation and clinicians who manage chronic respiratory care. Its work targets the COPD and severe asthma patient population, with benefits centered on simplifying dosing and expanding device options to fit existing treatment regimens.